These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Author: Robb AS, Chang W, Lee HK, Cook MS.
    Journal: J Child Adolesc Psychopharmacol; 2000; 10(4):327-30. PubMed ID: 11191694.
    Abstract:
    Neuroleptic malignant syndrome (NMS) is a potentially fatal complication of neuroleptic therapy, characterized by fever, rigidity, mental status changes, and autonomic instability. Although NMS was previously associated with the use of high-potency neuroleptics, cases have begun to emerge with atypical neuroleptics. This article presents a risperidone-induced case in the youngest patient to date, raising issues concerning our perceptions, the safety of newer neuroleptics, and treatment of NMS.
    [Abstract] [Full Text] [Related] [New Search]